Medicare Drug price control in the Inflation Reduction Act Moves Forward Except for Insulin
JAMA Network “How Do Commercial Insurance Plans Fare Under Proposed Prescription Drug Price Regulation?” Rena M. Conti, Richard G. Frank, Len M. Nichols December 2021, this article came out detailing Medicare negotiating directly with pharmaceutical companies and the impact of the negotiation on people insured by commercial plans. That is if commercial insurance plans were […]